Do analysts prefer SCPA or SYNT?

Synthomer has a consensus target price of GBX 119, indicating a potential upside of 14.64%. Given Synthomer's stronger consensus rating and higher possible upside, analysts plainly believe Synthomer is more favorable than Scapa Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Scapa Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Synthomer 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20

Which has preferable earnings & valuation, ZTF or SYNT?

Zotefoams has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zotefoams £176.29M 1.21 £9.80M £50.29 8.62 Synthomer £1.80B 0.09 -£82.04M -£73.60 N/A

Is ZTF or SYNT more profitable?

Zotefoams has a net margin of 13.88% compared to Synthomer's net margin of -6.81%. Zotefoams' return on equity of 18.18% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Zotefoams 13.88% 18.18% 5.48% Synthomer -6.81% -13.27% -0.28%

Which has higher valuation and earnings, SYNT or TET?

Treatt has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synthomer £1.80B 0.09 -£82.04M -£73.60 N/A Treatt £128.29M 1.40 £11.22M £7.22 42.24

Is SYNT or TET more profitable?

Treatt has a net margin of 3.40% compared to Synthomer's net margin of -6.81%. Treatt's return on equity of 3.22% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Synthomer -6.81% -13.27% -0.28% Treatt 3.40% 3.22% 6.72%

Which has higher valuation & earnings, IOF or SYNT?

Iofina has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Iofina £68.69M 1.46 £4.28M £4.00 13.10 Synthomer £1.80B 0.09 -£82.04M -£73.60 N/A

Is IOF or SYNT more profitable?

Iofina has a net margin of 12.91% compared to Synthomer's net margin of -6.81%. Iofina's return on equity of 15.30% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Iofina 12.91% 15.30% 5.18% Synthomer -6.81% -13.27% -0.28%

Do analysts rate HDD or SYNT?

Synthomer has a consensus target price of GBX 119, indicating a potential upside of 14.64%. Given Synthomer's stronger consensus rating and higher probable upside, analysts clearly believe Synthomer is more favorable than Hardide. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hardide 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Synthomer 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20

Which has higher valuation & earnings, HDD or SYNT?

Hardide has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Hardide, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hardide £8.02M 9.83 -£1.89M £1.80 55.56 Synthomer £1.80B 0.09 -£82.04M -£73.60 N/A

Is HDD or SYNT more profitable?

Hardide has a net margin of 15.60% compared to Synthomer's net margin of -6.81%. Hardide's return on equity of 32.49% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Hardide 15.60% 32.49% -9.80% Synthomer -6.81% -13.27% -0.28%

Synthomer (SYNT) Competitors

GBX 103.80 -4.40 (-4.07%)

As of 12:03 PM Eastern

Compare

SYNT vs. SCPA, ZTF, TET, IOF, and HDD

Should you buy Synthomer stock or one of its competitors? Synthomer's main competitors and comparable companies include Scapa Group (SCPA), Zotefoams (ZTF), Treatt (TET), Iofina (IOF), and Hardide (HDD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "specialty chemicals" industry.

How does Synthomer compare to Scapa Group?

Scapa Group (LON:SCPA) and Synthomer (LON:SYNT) are both small-cap materials companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Scapa Group has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Scapa Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Scapa Group	£281.80M	0.00	N/A	-£29.30	N/A
Synthomer	£1.80B	0.09	-£82.04M	-£73.60	N/A

Scapa Group has a net margin of 0.00% compared to Synthomer's net margin of -6.81%. Scapa Group's return on equity of 0.00% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Scapa Group	N/A	N/A	N/A
Synthomer	-6.81%	-13.27%	-0.28%

14.9% of Synthomer shares are held by institutional investors. 5.0% of Synthomer shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Synthomer has a consensus target price of GBX 119, indicating a potential upside of 14.64%. Given Synthomer's stronger consensus rating and higher possible upside, analysts plainly believe Synthomer is more favorable than Scapa Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Scapa Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Synthomer	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

In the previous week, Scapa Group's average media sentiment score of 0.00 equaled Synthomer'saverage media sentiment score.

Company	Overall Sentiment
Scapa Group	Neutral
Synthomer	Neutral

Summary

Synthomer beats Scapa Group on 7 of the 11 factors compared between the two stocks.

How does Synthomer compare to Zotefoams?

Zotefoams (LON:ZTF) and Synthomer (LON:SYNT) are both small-cap materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, media sentiment, valuation and risk.

Zotefoams has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zotefoams	£176.29M	1.21	£9.80M	£50.29	8.62
Synthomer	£1.80B	0.09	-£82.04M	-£73.60	N/A

In the previous week, Zotefoams' average media sentiment score of 0.00 equaled Synthomer'saverage media sentiment score.

Company	Overall Sentiment
Zotefoams	Neutral
Synthomer	Neutral

27.7% of Zotefoams shares are owned by institutional investors. Comparatively, 14.9% of Synthomer shares are owned by institutional investors. 4.5% of Zotefoams shares are owned by insiders. Comparatively, 5.0% of Synthomer shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Zotefoams currently has a consensus target price of GBX 605, suggesting a potential upside of 39.56%. Synthomer has a consensus target price of GBX 119, suggesting a potential upside of 14.64%. Given Zotefoams' stronger consensus rating and higher possible upside, research analysts plainly believe Zotefoams is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Synthomer	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

Zotefoams has a net margin of 13.88% compared to Synthomer's net margin of -6.81%. Zotefoams' return on equity of 18.18% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zotefoams	13.88%	18.18%	5.48%
Synthomer	-6.81%	-13.27%	-0.28%

Zotefoams has a beta of 1.238, meaning that its share price is 24% more volatile than the broader market. Comparatively, Synthomer has a beta of 1.044, meaning that its share price is 4% more volatile than the broader market.

Summary

Zotefoams beats Synthomer on 12 of the 14 factors compared between the two stocks.

How does Synthomer compare to Treatt?

Synthomer (LON:SYNT) and Treatt (LON:TET) are both small-cap materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Treatt has a net margin of 3.40% compared to Synthomer's net margin of -6.81%. Treatt's return on equity of 3.22% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synthomer	-6.81%	-13.27%	-0.28%
Treatt	3.40%	3.22%	6.72%

Synthomer presently has a consensus target price of GBX 119, suggesting a potential upside of 14.64%. Treatt has a consensus target price of GBX 242.50, suggesting a potential downside of 20.49%. Given Synthomer's higher possible upside, equities analysts clearly believe Synthomer is more favorable than Treatt.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synthomer	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20
Treatt	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Synthomer's average media sentiment score of 0.00 equaled Treatt'saverage media sentiment score.

Company	Overall Sentiment
Synthomer	Neutral
Treatt	Neutral

14.9% of Synthomer shares are held by institutional investors. Comparatively, 17.5% of Treatt shares are held by institutional investors. 5.0% of Synthomer shares are held by company insiders. Comparatively, 4.1% of Treatt shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Synthomer has a beta of 1.044, suggesting that its stock price is 4% more volatile than the broader market. Comparatively, Treatt has a beta of 0.907, suggesting that its stock price is 9% less volatile than the broader market.

Treatt has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synthomer	£1.80B	0.09	-£82.04M	-£73.60	N/A
Treatt	£128.29M	1.40	£11.22M	£7.22	42.24

Summary

Treatt beats Synthomer on 9 of the 13 factors compared between the two stocks.

How does Synthomer compare to Iofina?

Iofina (LON:IOF) and Synthomer (LON:SYNT) are both small-cap materials companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Iofina currently has a consensus price target of GBX 70, indicating a potential upside of 33.59%. Synthomer has a consensus price target of GBX 119, indicating a potential upside of 14.64%. Given Iofina's stronger consensus rating and higher probable upside, equities analysts clearly believe Iofina is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Synthomer	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

1.3% of Iofina shares are owned by institutional investors. Comparatively, 14.9% of Synthomer shares are owned by institutional investors. 13.4% of Iofina shares are owned by company insiders. Comparatively, 5.0% of Synthomer shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Iofina has a net margin of 12.91% compared to Synthomer's net margin of -6.81%. Iofina's return on equity of 15.30% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Iofina	12.91%	15.30%	5.18%
Synthomer	-6.81%	-13.27%	-0.28%

Iofina has a beta of 0.883, meaning that its share price is 12% less volatile than the broader market. Comparatively, Synthomer has a beta of 1.044, meaning that its share price is 4% more volatile than the broader market.

In the previous week, Iofina had 6 more articles in the media than Synthomer. MarketBeat recorded 6 mentions for Iofina and 0 mentions for Synthomer. Iofina's average media sentiment score of 0.30 beat Synthomer's score of 0.00 indicating that Iofina is being referred to more favorably in the media.

Company	Overall Sentiment
Iofina	Neutral
Synthomer	Neutral

Iofina has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Iofina	£68.69M	1.46	£4.28M	£4.00	13.10
Synthomer	£1.80B	0.09	-£82.04M	-£73.60	N/A

Summary

Iofina beats Synthomer on 12 of the 15 factors compared between the two stocks.

How does Synthomer compare to Hardide?

Hardide (LON:HDD) and Synthomer (LON:SYNT) are both small-cap materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends and institutional ownership.

In the previous week, Hardide had 4 more articles in the media than Synthomer. MarketBeat recorded 4 mentions for Hardide and 0 mentions for Synthomer. Synthomer's average media sentiment score of 0.00 beat Hardide's score of -0.06 indicating that Synthomer is being referred to more favorably in the news media.

Company	Overall Sentiment
Hardide	Neutral
Synthomer	Neutral

Hardide has a net margin of 15.60% compared to Synthomer's net margin of -6.81%. Hardide's return on equity of 32.49% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hardide	15.60%	32.49%	-9.80%
Synthomer	-6.81%	-13.27%	-0.28%

Synthomer has a consensus target price of GBX 119, indicating a potential upside of 14.64%. Given Synthomer's stronger consensus rating and higher probable upside, analysts clearly believe Synthomer is more favorable than Hardide.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hardide	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Synthomer	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

10.2% of Hardide shares are owned by institutional investors. Comparatively, 14.9% of Synthomer shares are owned by institutional investors. 65.7% of Hardide shares are owned by insiders. Comparatively, 5.0% of Synthomer shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Hardide has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Hardide, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hardide	£8.02M	9.83	-£1.89M	£1.80	55.56
Synthomer	£1.80B	0.09	-£82.04M	-£73.60	N/A

Hardide has a beta of 1.146, suggesting that its stock price is 15% more volatile than the broader market. Comparatively, Synthomer has a beta of 1.044, suggesting that its stock price is 4% more volatile than the broader market.

Summary

Hardide beats Synthomer on 9 of the 16 factors compared between the two stocks.

Get Synthomer News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SYNT vs. The Competition

Export

Metric	Synthomer	Chemicals Industry	Materials Sector	LON Exchange
Market Cap	£170.17M	£11.17B	£4.75B	£2.89B
Dividend Yield	28.47%	2.92%	4.73%	6.22%
P/E Ratio	-1.41	38.00	25.48	366.61
Price / Sales	0.09	48.54	16,510.75	89,510.94
Price / Cash	2.28	14.92	24.50	27.89
Price / Book	0.16	3.19	10.06	6.33
Net Income	-£82.04M	£222.40M	£157.81M	£5.89B
7 Day Performance	-7.32%	-1.51%	-1.70%	-0.12%
1 Month Performance	4.11%	-3.93%	-3.97%	5.22%
1 Year Performance	44.57%	16.75%	22.13%	18.52%

Synthomer Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SYNT Synthomer	1.5272 of 5 stars	GBX 103.80 -4.1%	GBX 119 +14.6%	+50.7%	£170.17M	£1.80B	N/A	4,200
SCPA Scapa Group	N/A	N/A	N/A	N/A	£402.98M	£281.80M	N/A	1,461
ZTF Zotefoams	N/A	GBX 428 -1.4%	GBX 605 +41.4%	+7.6%	£211.02M	£176.29M	8.51	549
TET Treatt	N/A	GBX 305 flat	GBX 242.50 -20.5%	N/A	£180.06M	£128.29M	42.24	350
IOF Iofina	3.5606 of 5 stars	GBX 53.25 -2.3%	GBX 70 +31.5%	+129.6%	£102.16M	£68.69M	13.31	95	Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:SYNT) was last updated on 9/28/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Synthomer (SYNT) Competitors

SYNT vs. SCPA, ZTF, TET, IOF, and HDD

How does Synthomer compare to Scapa Group?

Summary

How does Synthomer compare to Zotefoams?

Summary

How does Synthomer compare to Treatt?

Summary

How does Synthomer compare to Iofina?

Summary

How does Synthomer compare to Hardide?

Summary

Media Sentiment Over Time

SYNT vs. The Competition

Synthomer Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Synthomer (SYNT) Competitors

SYNT vs. SCPA, ZTF, TET, IOF, and HDD

How does Synthomer compare to Scapa Group?

Which has better earnings & valuation, SCPA or SYNT?

Is SCPA or SYNT more profitable?

Do institutionals and insiders hold more shares of SCPA or SYNT?

Do analysts prefer SCPA or SYNT?

Does the media prefer SCPA or SYNT?

Summary

How does Synthomer compare to Zotefoams?

Which has preferable earnings & valuation, ZTF or SYNT?

Does the media refer more to ZTF or SYNT?

Do insiders & institutionals hold more shares of ZTF or SYNT?

Do analysts rate ZTF or SYNT?

Is ZTF or SYNT more profitable?

Which has more risk and volatility, ZTF or SYNT?

Summary

How does Synthomer compare to Treatt?

Is SYNT or TET more profitable?

Do analysts rate SYNT or TET?

Does the media favor SYNT or TET?

Do insiders & institutionals have more ownership in SYNT or TET?

Which has more risk and volatility, SYNT or TET?

Which has higher valuation and earnings, SYNT or TET?

Summary

How does Synthomer compare to Iofina?

Do analysts rate IOF or SYNT?

Do insiders & institutionals believe in IOF or SYNT?

Is IOF or SYNT more profitable?

Which has more volatility & risk, IOF or SYNT?

Does the media prefer IOF or SYNT?

Which has higher valuation & earnings, IOF or SYNT?

Summary

How does Synthomer compare to Hardide?

Does the media refer more to HDD or SYNT?

Is HDD or SYNT more profitable?

Do analysts rate HDD or SYNT?

Do insiders and institutionals believe in HDD or SYNT?

Which has higher valuation & earnings, HDD or SYNT?

Which has more volatility and risk, HDD or SYNT?

Summary

Media Sentiment Over Time

SYNT vs. The Competition

Synthomer Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools